What exactly changed in the March 06, 2026 PGNY analyst rating from Jefferies?

Jefferies maintained a **Buy** on PGNY and lowered its price target to **$30** from **$36** on March 06, 2026 at 12:01 PM, reflecting continued confidence but reduced near-term upside.

Does the PGNY analyst rating change mean I should sell shares now?

No. A maintained Buy with a lower price target usually signals continued long-term support but lower near-term upside, so consider your time horizon and risk tolerance before making trades.

How should investors use the new PGNY price target and analyst rating?

Use the **$30** price target and the maintained Buy as inputs for position sizing and horizon planning, and compare analyst views alongside Meyka AI’s grade and company financials.

Where can I read the original analyst note and reporting on the PGNY analyst rating?

Primary coverage of the note appears on StreetInsider and investing summaries are available on Investing.com; consult both for full context and caveats.

Analyst Ratings

Jefferies Maintains Buy on PGNY (Progyny, Inc.) March 2026

ByHuzaifa Zahoor March 7, 2026March 7, 2026

Jefferies maintained a Buy on PGNY (Progyny, Inc.) on March 06, 2026 while cutting its price target to $30 from $36. This PGNY analyst rating update was logged at 12:01 PM and shows the firm still favors the stock despite trimming upside. Jefferies cited valuation and near-term outlook in its note, and the firm’s action follows modest share movement, with the stock changing by 4.56% ($0.8) since the prior point of reference. Investors should read this PGNY analyst rating as a vote of confidence tempered by caution on near-term growth assumptions.